Mogi M, Harada M, Hiraoka B Y, Fukasawa K, Komatsu M, Nagatsu T
Arch Oral Biol. 1986;31(7):505-7. doi: 10.1016/0003-9969(86)90028-2.
A highly-sensitive sandwich enzyme immunoassay for serum dipeptidyl aminopeptidase IV (DAP IV) was developed; its level in sera of patients with oral cancer [1.50 +/- 0.35(SD)mg/l serum] was significantly lower than in normal subjects [2.27 +/- 0.77(SD)mg/l serum].
开发了一种用于血清二肽基氨基肽酶IV(DAP IV)的高灵敏度夹心酶免疫测定法;口腔癌患者血清中该酶水平[1.50±0.35(标准差)mg/l血清]显著低于正常受试者[2.27±0.77(标准差)mg/l血清]。